Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Raphael Ikogho"'
Autor:
Raphael Ikogho, Johannes Hammel, Gazanfer Belge, Petra Anheuser, Christian Wülfing, Arlo Radtke, Finja Hennig, Klaus-Peter Dieckmann
Publikováno v:
Urologia internationalis. 100(4)
Background: Accumulating evidence suggests serum levels of microRNA (miR)-371a-3p to be a novel tumour marker of testicular germ cell tumours (GCTs). Presently, there is only limited information regarding the velocity of decline of serum levels in re
Autor:
Hanna Richter-Simonsen, Uwe Pichlmeier, Klaus-Peter Dieckmann, Magdalena Kulejewski, Henrik Zecha, Hendrik Isbarn, Petra Anheuser, Raphael Ikogho
Publikováno v:
Urologia internationalis. 100(4)
Introduction: Clinical characteristics of testicular germ cell tumours (GCTs) apparently change over time, and some vary geographically. The aim of this study is to document the clinical profile of contemporary GCT patients. Patients and Methods: Fou
Autor:
Thomas Balks, Gazanfer Belge, Raphael Ikogho, Nina Winter, Jörn Bullerdiek, Meike Spiekermann, Klaus-Peter Dieckmann
Publikováno v:
Andrology. 3:78-84
Summary As only 60% of the patients with germ cell tumour (GCT) express the classical markers, new markers as for example microRNAs (miRNAs) are required. One promising candidate is miR-371a-3p, but data are sparse to date. We measured serum levels o
Autor:
Petra Anheuser, Thomas Loening, Werner Wosniok, Thomas Balks, Klaus-Peter Dieckmann, Raphael Ikogho, Gazanfer Belge, Jörn Bullerdiek, Meike Spiekermann
Publikováno v:
Urologia internationalis. 97(1)
Background: microRNAs (miRs)-371-3 are suggested to be novel biomarkers of germ cell tumors (GCTs), but their specificity is unresolved. We aimed at clarifying the origin of miR 371a-3p by measuring this miR in peripheral vein blood, and in fluids pr
Autor:
Sven Philip Aries, Petra Anheuser, Ralf Gehrckens, Raphael Ikogho, Wiebke Hollburg, Klaus-Peter Dieckmann
Publikováno v:
BMC Urology
Background Major life-threatening complications secondary to cisplatin-based chemotherapy are rare in patients with testicular germ cell tumour (GCT). The incidence of complications increases with dosage of chemotherapy and with a variety of patient-